Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | KCNH3 | Q9ULD8 | 2/20 | 0.53 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | DNM2 | P50570 | 7/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | RAD52 | P43351 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11787843 | 1.00 | KMT2A (0.83) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL20694824 | 0.98 | KMT2A (0.81) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL7100653 | 0.98 | KMT2A (0.80) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL20680484 | 0.96 | KMT2A (0.78) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL1562316 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL10912439 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL2238412 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL17563553 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL7937257 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR | |
| SCHEMBL2328267 | 0.96 | KMT2A (0.77) | KMT2ALMNAKCNH3NR1I2AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11299504-B2 | Process for preparing a triazine-based precursor, the precursor prepared thereby, a method for producing a micro-particulate complex using the precursor, and the micro-particulate complex produced thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2022-04-12 | — | — | US | disclosed |
| CN-109400543-B | Triazine precursor, method for preparing triazine precursor and application of triazine precursor | 暨南国际大学 | 2022-03-01 | — | — | CN | disclosed |
| US-20200369687-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2020-11-26 | — | — | US | disclosed |
| CN-109400543-A | Triazine precursor, method for preparing triazine precursor and application of triazine precursor | 暨南国际大学 | 2019-03-01 | — | — | CN | disclosed |
| US-20190055270-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | NATIONAL CHI NAN UNIVERSITY (TW) | 2019-02-21 | — | — | US | disclosed |
| US-6316619-B1 | USED AS LIGHT STABILIZER FOR ORGANIC MATERIALS SUCH AS POLYETHYLENE AND POLYPROPYLENE; LOW MELTING POINT, BLEEDING RESISTANCE | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2001-11-13 | — | — | US | disclosed |
| EP-0127162-B1 | COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4555479-A | CONTAINING 5-PYRAZOLONE TYPE MAGENTA COUPLERS AND NITROGEN COMPOUND-PREVENTION STAINING | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-26 | — | — | US | disclosed |
| EP-0127162-A2 | Color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-12-05 | — | — | EP | disclosed |
| US-3931165-A | INSECTICIDES, HERBICIDES | BARER SOL J | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190055270-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885LMNA 3011/4885KCNH3 4402/4885 |
| US-11299504-B2 | Process for preparing a triazine-based precursor, the precursor prepared thereby, a method for producing a micro-particulate complex using the precursor, and the micro-particulate complex produced thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885LMNA 3011/4885KCNH3 4402/4885 |
| US-20200369687-A1 | Process for Preparing a Triazine-Based Precursor, the Precursor Prepared Thereby, a Method for Producing a Micro-Particulate Complex Using the Precursor, and the Micro-Particulate Complex Produced Thereby | SSRP1, RRP15, SUB1 | KMT2A 2946/4885LMNA 3011/4885KCNH3 4402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.